HDN and RELISYS showcase breakthrough cardiovascular solutions at VICC 2026
Held on November 7–8, 2026, at the Pandora Convention Center, Hai Phong City, Vietnam, the conference brought together the interventional cardiology community for valuable scientific exchange, knowledge sharing, and meaningful interactions.
On November 7–8, 2026, the 12th National Interventional Cardiology Conference (VICC 2026), themed "Acute Cardiovascular Intervention: Forging Courage and Technological Breakthroughs," concluded successfully at the Pandora Center Event Organization Center in Hai Phong City. It is an annual scientific forum organized by the Vietnam National Heart Association and the Vietnam Interventional Cardiology Society (VICS). This year, the event drew more than 1,500 delegates, including leading domestic and international experts, professors, and physicians, and featured large-scale academic activities, including scientific report sessions and live cases.
Overview of the VICC 2026 opening session on November 7
As the exclusive distributor of RELISYS solutions in Vietnam, HDN Investment Joint Stock Company was honored to accompany the conference with an exhibition booth showcasing the range of cardiovascular intervention products distributed by HDN, including drug-eluting stents, coronary balloons, and transcatheter aortic valve implantation (TAVI) bioprosthetic valves.
Among them, the Vienna Aortic Valve and the TricValve are two new, prominent technologies featuring superior design and functionality, minimally invasive treatment capabilities, optimized procedure times, and enhanced safety for patients.
The booth received positive feedback from delegates regarding these two breakthrough valve designs on both November 7 and 8.
VICC 2026 is a major professional event bringing together many leading experts in the field of interventional cardiology. At the exhibition booth, HDN and RELISYS comprehensively introduced an ecosystem of medical devices and advanced intervention solutions, meeting the contemporary challenges in cardiovascular emergency and treatment.
Also, the HDN and RELISYS booth was honored to receive a great deal of interest and positive inquiries from delegates, the chair committee, and leading experts from major Cathlab centers nationwide. Doctors and partners interested in solutions from RELISYS can find more information here.
Let's look back at some photos from the Conference: Representatives of HDN and RELISYS at the 12th National Interventional Cardiology Conference (VICC 2026):
Representatives of HDN and RELISYS at VICC 2026
Modern cardiovascular intervention solutions displayed and introduced by HDN and Relisys right at the exhibition booth: Drug-eluting stents, coronary balloons, and transcatheter bioprosthetic heart valves.
HDN extends our deepest gratitude to the organizers, doctors, and all delegates who visited our booth and contributed to making VICC 2026 a memorable and highly successful event!
HDN INVESTMENT JOINT STOCK COMPANY Head Office: 3rd Floor, HH2 Bac Ha Building, 15 To Huu Street, Thanh Xuan Ward, Hanoi, Vietnam Ho Chi Minh City Branch: No. 283/21 Cach Mang Thang 8 Street, Hoa Hung Ward, Ho Chi Minh City, Vietnam Nghe An Branch: No. 39 Le Hong Phong Street, Thanh Vinh Ward, Nghe An Province, Vietnam Da Nang Representative Office: No. 2 Le Dinh Ly Street, Thanh Khe District, Da Nang City, Vietnam Email: ctyhdn@fpt.vn | Website: hdn.com.vn | Tel: (+84) 24 353 77463 - (+84) 964287966
On October 9, a specialized seminar on the technology and applications of advanced 3T magnetic resonance imaging (MRI) in neurovascular and musculoskeletal fields was held in Nghe An. The program was a scientific event jointly organized by GE HealthCare and Minh An General Hospital.
Last weekend, HDN Investment Joint Stock Company (HDN), in collaboration with GE HealthCare and the Hope Foundation (VnExpress newspaper), successfully organized the "Miracle Fair - Synchronized Hearts" program for hundreds of pediatric patients in Nghe An, Vietnam.
HDN Investment Joint Stock Company and Relisys Medical Devices Limited are pleased to announce the successful participation in Vietnam Valves 2026, held from September 25 to 26, 2026, at the New World Saigon Hotel in Ho Chi Minh City, Vietnam.
Held on November 7–8, 2026, at the Pandora Convention Center, Hai Phong City, Vietnam, the conference brought together the interventional cardiology community for valuable scientific exchange, knowledge sharing, and meaningful interactions.
On October 9, a specialized seminar on the technology and applications of advanced 3T magnetic resonance imaging (MRI) in neurovascular and musculoskeletal fields was held in Nghe An. The program was a scientific event jointly organized by GE HealthCare and Minh An General Hospital.
Last weekend, HDN Investment Joint Stock Company (HDN), in collaboration with GE HealthCare and the Hope Foundation (VnExpress newspaper), successfully organized the "Miracle Fair - Synchronized Hearts" program for hundreds of pediatric patients in Nghe An, Vietnam.
HDN Investment Joint Stock Company and Relisys Medical Devices Limited are pleased to announce the successful participation in Vietnam Valves 2026, held from September 25 to 26, 2026, at the New World Saigon Hotel in Ho Chi Minh City, Vietnam.
On August 7, Trans-Asia General Hospital System officially signed an agreement with HDN Investment Joint Stock Company (HDN) to invest in and procure diagnostic imaging systems from GE HealthCare.
From 24–26 July, Crowne Plaza Da Nang welcomed leading respiratory physicians and interventional pulmonology specialists from Vietnam and abroad for the Vietnam Respiratory Society Annual Scientific Congress (VNRS 2026).
On the evening of 24 July, HDN Investment Joint Stock Company, in collaboration with ForTsing Medical (Hong Kong), organized a pre-congress Dinner Symposium entitled "A New Era of AI Technology in Interventional Pulmonology" at Crowne Plaza Da Nang, ahead of the Vietnam Respiratory Society Annual Scientific Congress (VNRS 2026).
Over the past two decades, HDN has steadily strengthened its position by building on core values centered around product quality, professional service, and the trust of customers and strategic partners.
As a strategic distribution partner of GE HealthCare in Vietnam, HDN’s participation reaffirmed the company’s strong market development capabilities, implementation expertise, and long-term commitment to accompanying GE HealthCare in delivering advanced medical technologies to healthcare facilities across Vietnam.